| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/15/2007 | WO2006129828A3 Target substance capturing molecule |
| 02/15/2007 | WO2006124678A3 Corn plants and seed enhanced for asparagine and protein |
| 02/15/2007 | WO2006122791A3 Tirc7 as marker for detecting early immune activation |
| 02/15/2007 | WO2006122650A3 Isolated aqdecay photoprotein and use thereof |
| 02/15/2007 | WO2006116005A3 Stabilization of cardiac troponin |
| 02/15/2007 | WO2006111743A3 Identifying lantibiotic gene clusters and novel lantibiotic genes |
| 02/15/2007 | WO2006106521A8 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| 02/15/2007 | WO2006104964A3 Inhibition of wet type age related macular degeneration (amd) by adiponectin or acrp 30 |
| 02/15/2007 | WO2006094756A3 Varicella zoster virus vaccine |
| 02/15/2007 | WO2006094724A3 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 02/15/2007 | WO2006094106A3 Anti-angiogenic methods and compositions |
| 02/15/2007 | WO2006082304A3 Novel peptides which interact with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 02/15/2007 | WO2006081826A3 Survivin peptide vaccine |
| 02/15/2007 | WO2006074437A8 Nucleotide sequences encoding ramosa3 and sister of ramosa3 and methods of use for same |
| 02/15/2007 | WO2006071933A3 Hetero-oligomeric hiv envelope proteins |
| 02/15/2007 | WO2006031992A3 Increasing hemoglobin and other heme protein production in bacteria by co-expression of heme transport genes |
| 02/15/2007 | WO2006014253A3 Factor viia variants |
| 02/15/2007 | WO2006004955A3 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics and phenotypes |
| 02/15/2007 | WO2005113059A3 Disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 02/15/2007 | WO2005020934A3 Fsh glycosylation mutant |
| 02/15/2007 | WO2005013904A3 Sars nucleic acids, proteins, vaccines, and uses thereof |
| 02/15/2007 | WO2003099854A3 Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides |
| 02/15/2007 | US20070039073 Novel synthetic genes for plant gums |
| 02/15/2007 | US20070039070 transforming plant cells with a DNA construct comprising nucleic acid sequences, Eucalyptus caffeic acid 3-O-methyltransferase (COMT) promoters and nucleic acid sequence that code for polypeptides, then culturing said transformed plant cells, to producing transgenic plants |
| 02/15/2007 | US20070039067 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 02/15/2007 | US20070038380 Crystal structure of E.coli GDP-fucose synthetase (and complexes thereof) and methods of identifying agonists and antagonists using same |
| 02/15/2007 | US20070037970 Interleukin-17 receptor homologue |
| 02/15/2007 | US20070037969 Interleukin-17 receptor homologue |
| 02/15/2007 | US20070037968 Human cytokine receptor designated as Zcytor14 polypeptide; antiinflammatory agent |
| 02/15/2007 | US20070037967 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 02/15/2007 | US20070037966 Hydrophobic interaction chromatography purification of factor VII polypeptides |
| 02/15/2007 | US20070037965 Fusion proteins; human cytokine receptors; usefulness in both basic research and as therapeutics |
| 02/15/2007 | US20070037964 Chemoselective ligation |
| 02/15/2007 | US20070037963 Differentially protected orthogonal lanthionine technology |
| 02/15/2007 | US20070037768 Methods for therapy of neurodegenerative disease of the brain |
| 02/15/2007 | US20070037766 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 02/15/2007 | US20070037763 Oligonucleotide compound and method for treating nidovirus infections |
| 02/15/2007 | US20070037750 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 02/15/2007 | US20070037749 Administering a N-terminus modified polypeptide derived from the fibrin alpha or beta chain; antiinflammatory agent, anticoagulants; transplant rejection; arteriosclerosis |
| 02/15/2007 | US20070037747 Exendin 4 polypeptide fragment |
| 02/15/2007 | US20070037746 Novel compounds |
| 02/15/2007 | US20070037745 Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer |
| 02/15/2007 | US20070037744 Human cathelicidin antimicrobial peptides |
| 02/15/2007 | US20070037743 Novel conotoxin modulating sodium channels |
| 02/15/2007 | US20070037741 Novel compositions and methods for the treatment of immune related disease |
| 02/15/2007 | US20070037736 Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury |
| 02/15/2007 | US20070037734 purification from a fluid comprising hydrophobic charge-induction chromatography; comprising loading a fluid selected from urine or cell culture supernatant and containing IL-18BP onto an equilibrated hydrophobic charge-induction chromatography resin |
| 02/15/2007 | US20070037262 Genes encoding genetic stability, gene expression and folding proteins |
| 02/15/2007 | US20070037258 Methods and compositions for enhancing protein folding |
| 02/15/2007 | US20070037257 Nucleic acid, expression vectors and host cells for synthetic genes, chosen from a gram negative bacteria, yeast, or mammalian cell; zinc-endopeptidases that specifically cleave the synaptosomal proteins, SNAP-25, VAMP, or syntaxin at discrete sites |
| 02/15/2007 | US20070037256 Determining whether a DNA sequence comprises a gene transcription modulating quality and/or a gene transcription repressing quality; systematic elucidation and identification of regulatory sequences |
| 02/15/2007 | US20070037254 Expression Vectors and Methods |
| 02/15/2007 | US20070037253 18-Residue dimerized peptide designated PIP [59-67] dimer, having dual inhibitory activity against secretory phospholipase A2 (sPLA2) and matrix metalloproteinases (MMPs); acute pancreatitis; infection; neurodegenerative disease; neuronal excitotoxicity |
| 02/15/2007 | US20070037248 Production of modified glycoproteins having multiple antennary structures |
| 02/15/2007 | US20070037246 Methods and compositions for enhanced protein expression and purification |
| 02/15/2007 | US20070037245 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
| 02/15/2007 | US20070037230 Peptides for selectively and specifically binding Bacillus anthracis spores and use thereof in landscape phages |
| 02/15/2007 | US20070037219 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof |
| 02/15/2007 | US20070037218 Human gene critical to fertility |
| 02/15/2007 | US20070037211 Peptide antagonists for inhibiting heat shock protein (Hsp 16.3) of mycobacterium tuberculosis |
| 02/15/2007 | US20070037210 Cytokine receptor modulators, method of identifying same, and method of modulating cytokine receptors activity with same |
| 02/15/2007 | US20070037209 a fragment derived from the MET ectodomain in monomer form binds to hepatocyte growth factor/scatter factor (HGF/SF) either in the presence or absence of heparin; method for determining whether an agent binds to a MET ectodomain fragment in monomeric form |
| 02/15/2007 | US20070037204 protein encoded by the nucleotide sequence represented by SEQ ID NO: 1 to 65 ; useful for diagnosing and treating cancer |
| 02/15/2007 | US20070037203 Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor |
| 02/15/2007 | US20070037202 Potentiation of cancer therapies by ZNF217 inhibition |
| 02/15/2007 | US20070037193 Modulation of peroxisome proliferator-activated receptors |
| 02/15/2007 | US20070037191 Apo-2DcR |
| 02/15/2007 | US20070037188 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's diseases; contacting a target cell with a test compound, measuring the levels of reporter gene transcription that occurs in the presence and absence of the test compound; comparing the levels of reporter gene transcription |
| 02/15/2007 | US20070037164 Tumor necrosis factor alpha |
| 02/15/2007 | US20070037163 Nucleic acid and amino acid sequences relating to staphylococcus epidermidis for diagnostics and therapeutics |
| 02/15/2007 | US20070037161 Motoneuronotrophic factor gene sequences |
| 02/15/2007 | US20070037160 Method for the dissociation of the extracellular haemoglobin molecule of <I> arenicola marina </I> and the characterisation of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains |
| 02/15/2007 | US20070037158 Methods of modulating bone growth, bone remodeling and adiposity |
| 02/15/2007 | US20070037151 Cd4+ human papillomavirus (hpv) epitopes |
| 02/15/2007 | US20070037149 Human calcium transporter 1 gene, screening method of calcium absorption regulating factor, and calcium absorption regulating factor |
| 02/15/2007 | US20070037147 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/15/2007 | US20070037145 drug screening; for carcinomas, especially lymphoma carcinomas |
| 02/15/2007 | US20070037141 comprise DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 02/15/2007 | US20070037133 Biomimetic infrared sensor containing a temperature-sensing helical coiled-coil protein, TlpA8, incorporated into an electroconductive film or gel; lightweight, high sensitivity and excellent dynamic range |
| 02/15/2007 | US20070036826 Influenza immunogen and vaccine |
| 02/15/2007 | US20070036824 Optimized expression of hpv 58 l1 in yeast |
| 02/15/2007 | US20070036819 Plasmodium placental polypeptide for use in generating vaccine for treatment and prevention of malarial infection |
| 02/15/2007 | US20070036818 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria |
| 02/15/2007 | US20070036817 Immunopotentiating effect of a fomitella fraxinea-derived lectin on chicken immunity and resistance to coccidiosis |
| 02/15/2007 | US20070036816 Tuberculosis antigen detection assays and vaccines |
| 02/15/2007 | US20070036815 Ricin-like toxins for treatment of cancer |
| 02/15/2007 | US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
| 02/15/2007 | US20070036812 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine |
| 02/15/2007 | US20070036810 Cyclic amp response element activator proteins and uses related thereto |
| 02/15/2007 | US20070036808 Cancer antigen peptide formulations |
| 02/15/2007 | US20070036806 have an increased half-life, decreased immunogenicity, and reduce effector activity; diabetes, obesity, irritable bowel syndrome and other conditions that would be benefited by lowering plasma glucose, inhibiting gastric and/or intestinal motility and inhibiting gastric and/or intestinal emptying |
| 02/15/2007 | US20070036799 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 02/15/2007 | US20070036793 Methods for use of an lkb1/strad7mo25 complex |
| 02/15/2007 | US20070036791 Interleukin-17 receptor homologue |
| 02/15/2007 | US20070036789 Neutralizable Epitope of HGF and Neutralizing Antibody Binding to the Same |
| 02/15/2007 | US20070036788 Use of a compound for reducing the biological effectiveness of il-6 |
| 02/15/2007 | US20070036782 Apo-2 ligand |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036778 Staphylococcus; immunogens; immumostimulatory sequences; cationic peptides |
| 02/15/2007 | US20070036769 BMP pathway methods and compositions |